AMLODIPINE

AMLODIPINE was reported 272638 times

AMLODIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-CARDIOGENIC PULMONARY OEDEMA 365 0.3450
1 DISTRIBUTIVE SHOCK 766 0.3379
2 VASOPLEGIA SYNDROME 530 0.3230
3 GINGIVAL HYPERTROPHY 461 0.3037
4 HYPERPARATHYROIDISM SECONDARY 547 0.2181
5 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 221 0.2081
6 NEPHROGENIC ANAEMIA 962 0.2075
7 CAROTID ARTERY THROMBOSIS 165 0.1943
8 BRASH SYNDROME 255 0.1816
9 SUSPECTED SUICIDE 786 0.1676
10 BLOOD PRESSURE SYSTOLIC ABNORMAL 333 0.1346
11 ADJUSTMENT DISORDER 167 0.1285
12 BLOOD PRESSURE DIASTOLIC ABNORMAL 310 0.1218
13 REBOUND ACID HYPERSECRETION 347 0.1146
14 PHYSICAL DECONDITIONING 284 0.1102
15 END STAGE RENAL DISEASE 1989 0.1089
16 SEDATION COMPLICATION 272 0.1065
17 CREATININE RENAL CLEARANCE DECREASED 325 0.0811
18 SHOCK 1794 0.0779
19 DIASTOLIC DYSFUNCTION 232 0.0751
20 BLOOD PRESSURE INADEQUATELY CONTROLLED 452 0.0751
21 PERSONALITY DISORDER 194 0.0740
22 BLOOD PRESSURE SYSTOLIC INCREASED 1437 0.0736
23 LEFT VENTRICULAR HYPERTROPHY 312 0.0728
24 HYPOMAGNESAEMIA 1004 0.0720
25 CHRONIC KIDNEY DISEASE 5425 0.0713
26 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 174 0.0703
27 ORTHOSTATIC HYPOTENSION 1211 0.0695
28 ATRIOVENTRICULAR BLOCK FIRST DEGREE 299 0.0689
29 BREATH SOUNDS ABNORMAL 337 0.0683
30 METABOLIC ACIDOSIS 2162 0.0675
31 COMPLETED SUICIDE 5565 0.0667
32 ACUTE KIDNEY INJURY 9956 0.0650
33 CARDIOGENIC SHOCK 933 0.0650
34 APLASTIC ANAEMIA 336 0.0643
35 BLOOD PRESSURE DIASTOLIC DECREASED 470 0.0636
36 HYPERTENSIVE CRISIS 680 0.0611
37 POTENTIATING DRUG INTERACTION 200 0.0595
38 GINGIVAL SWELLING 258 0.0584
39 HAEMODYNAMIC INSTABILITY 443 0.0581
40 TUBULOINTERSTITIAL NEPHRITIS 1079 0.0575
41 LACTIC ACIDOSIS 1845 0.0569
42 HYPERKALAEMIA 1978 0.0563
43 ATRIOVENTRICULAR BLOCK COMPLETE 374 0.0558
44 BLOOD LACTIC ACID INCREASED 293 0.0556
45 BENIGN PROSTATIC HYPERPLASIA 283 0.0547
46 RALES 317 0.0545
47 AORTIC STENOSIS 188 0.0539
48 INTENTIONAL OVERDOSE 3454 0.0538
49 HYPONATRAEMIA 2984 0.0529
50 OLIGURIA 324 0.0521
51 BRADYCARDIA 2764 0.0521
52 BLOOD PRESSURE FLUCTUATION 1232 0.0513
53 PROTEIN URINE PRESENT 255 0.0511
54 HYPOKALAEMIA 2361 0.0511
55 ANURIA 439 0.0510
56 BLOOD PRESSURE DIASTOLIC INCREASED 231 0.0500
57 SINUS BRADYCARDIA 483 0.0499
58 NOCTURIA 603 0.0496
59 BRONCHIECTASIS 332 0.0492
60 RENAL FUNCTION TEST ABNORMAL 226 0.0486
61 GLOMERULAR FILTRATION RATE DECREASED 595 0.0484
62 CAROTID ARTERY STENOSIS 167 0.0478
63 HYPERVOLAEMIA 236 0.0477
64 HYPERURICAEMIA 196 0.0476
65 BLOOD CALCIUM DECREASED 531 0.0472
66 BODY TEMPERATURE DECREASED 461 0.0468
67 OBSTRUCTIVE AIRWAYS DISORDER 519 0.0466
68 RENAL TUBULAR NECROSIS 457 0.0465
69 CUTANEOUS VASCULITIS 168 0.0460
70 CIRCULATORY COLLAPSE 779 0.0457
71 PEMPHIGOID 344 0.0455
72 BLOOD URIC ACID INCREASED 262 0.0453
73 RENAL INJURY 1314 0.0442
74 DYSPNOEA EXERTIONAL 1662 0.0441
75 BLOOD MAGNESIUM DECREASED 380 0.0440
76 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 179 0.0438
77 HYPOTENSION 8782 0.0437
78 IRON DEFICIENCY 195 0.0433
79 HYPOVOLAEMIA 253 0.0432
80 BUNDLE BRANCH BLOCK LEFT 183 0.0431
81 BLOOD PRESSURE SYSTOLIC DECREASED 196 0.0430
82 PULSELESS ELECTRICAL ACTIVITY 180 0.0430
83 ARTERIAL OCCLUSIVE DISEASE 338 0.0430
84 BLOOD PRESSURE INCREASED 6537 0.0427
85 KIDNEY TRANSPLANT REJECTION 205 0.0427
86 HYPOCALCAEMIA 804 0.0424
87 GINGIVAL PAIN 338 0.0424
88 BLOOD CREATININE INCREASED 2771 0.0424
89 HEMIPLEGIA 349 0.0419
90 GOUT 751 0.0418
91 HYPOVOLAEMIC SHOCK 200 0.0417
92 HAEMORRHAGIC ANAEMIA 183 0.0416
93 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 425 0.0414
94 VASCULITIS 481 0.0412
95 ACIDOSIS 315 0.0412
96 BUNDLE BRANCH BLOCK RIGHT 187 0.0407
97 PROTEINURIA 774 0.0407
98 RENAL FAILURE 5339 0.0402
99 SPRUE-LIKE ENTEROPATHY 198 0.0401
100 HEART RATE DECREASED 1408 0.0401
101 TROPONIN INCREASED 305 0.0400
102 DIVERTICULUM INTESTINAL 175 0.0400
103 PULMONARY OEDEMA 1791 0.0400
104 UPPER GASTROINTESTINAL HAEMORRHAGE 670 0.0398
105 MAJOR DEPRESSION 289 0.0395
106 ANGINA PECTORIS 1132 0.0395
107 HYPOTHERMIA 398 0.0393
108 TOXICITY TO VARIOUS AGENTS 6620 0.0392
109 DRUG INTERACTION 6228 0.0392
110 RENAL IMPAIRMENT 3295 0.0392
111 DRUG LEVEL INCREASED 649 0.0392
112 HYPERCALCAEMIA 484 0.0392
113 GANGRENE 235 0.0390
114 HAIR DISORDER 321 0.0389
115 CARDIAC FAILURE ACUTE 259 0.0388
116 HYPERTENSION 8229 0.0388
117 HAIR COLOUR CHANGES 483 0.0388
118 ISCHAEMIA 178 0.0387
119 MICTURITION URGENCY 441 0.0386
120 RENAL CYST 304 0.0382
121 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 338 0.0382
122 OEDEMA PERIPHERAL 4622 0.0379
123 HYPOPHOSPHATAEMIA 280 0.0378
124 URINE OUTPUT DECREASED 331 0.0378
125 NEPHROPATHY 351 0.0376
126 GINGIVAL BLEEDING 512 0.0375
127 NEPHROTIC SYNDROME 257 0.0375
128 HYPOXIA 1316 0.0373
129 FULL BLOOD COUNT ABNORMAL 395 0.0373
130 GINGIVITIS 201 0.0372
131 ABNORMAL LOSS OF WEIGHT 254 0.0372
132 NEUTROPENIC SEPSIS 266 0.0372
133 ACUTE RESPIRATORY FAILURE 716 0.0372
134 CORONARY ARTERY STENOSIS 187 0.0371
135 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 190 0.0370
136 INTESTINAL ISCHAEMIA 204 0.0370
137 ELECTROLYTE IMBALANCE 430 0.0370
138 SEROTONIN SYNDROME 708 0.0368
139 RHINITIS 297 0.0368
140 HYPERKERATOSIS 203 0.0368
141 ERYSIPELAS 184 0.0366
142 SWOLLEN TONGUE 1141 0.0365
143 BLOOD UREA INCREASED 610 0.0364
144 RHABDOMYOLYSIS 1512 0.0362
145 MYOPATHY 313 0.0362
146 ANGIOEDEMA 1597 0.0361
147 ACUTE MYOCARDIAL INFARCTION 1063 0.0360
148 YELLOW SKIN 168 0.0358
149 JOINT SWELLING 4328 0.0358
150 BLOOD POTASSIUM INCREASED 581 0.0357
151 UROSEPSIS 330 0.0357
152 COLITIS MICROSCOPIC 169 0.0356
153 BLOOD PRESSURE ABNORMAL 703 0.0353
154 PERIPHERAL SWELLING 5440 0.0353
155 SPUTUM DISCOLOURED 334 0.0352
156 HYPERLIPIDAEMIA 419 0.0350
157 ATRIOVENTRICULAR BLOCK 270 0.0349
158 MITRAL VALVE INCOMPETENCE 395 0.0349
159 ATRIAL FLUTTER 278 0.0348
160 HEMIPARESIS 584 0.0344
161 BLOOD POTASSIUM DECREASED 1036 0.0344
162 DIZZINESS POSTURAL 333 0.0343
163 EXERCISE TOLERANCE DECREASED 197 0.0342
164 ACUTE CORONARY SYNDROME 283 0.0341
165 SENSORY LOSS 275 0.0341
166 HYPERCHOLESTEROLAEMIA 329 0.0340
167 HYPERGLYCAEMIA 1238 0.0339
168 BLOOD SODIUM DECREASED 640 0.0339
169 RENAL CELL CARCINOMA 166 0.0339
170 COLITIS ISCHAEMIC 227 0.0336
171 POLYURIA 275 0.0335
172 MELAENA 736 0.0334
173 LEUKOCYTOSIS 604 0.0333
174 POLYP 218 0.0333
175 CARDIAC MURMUR 287 0.0331
176 FLUID OVERLOAD 482 0.0331
177 RENAL FAILURE CHRONIC 254 0.0330
178 LARGE INTESTINE POLYP 228 0.0329
179 ELECTROCARDIOGRAM ABNORMAL 258 0.0328
180 BASAL CELL CARCINOMA 512 0.0328
181 IRON DEFICIENCY ANAEMIA 302 0.0327
182 CARDIOMEGALY 402 0.0326
183 HYPOGLYCAEMIA 1579 0.0325
184 SUBDURAL HAEMATOMA 466 0.0325
185 SINUS CONGESTION 439 0.0325
186 ATRIAL FIBRILLATION 3164 0.0325
187 OEDEMA 1752 0.0323
188 TASTE DISORDER 654 0.0322
189 RESPIRATORY RATE INCREASED 286 0.0322
190 OXYGEN SATURATION DECREASED 1804 0.0321
191 ACUTE RESPIRATORY DISTRESS SYNDROME 567 0.0320
192 SUICIDE ATTEMPT 1925 0.0317
193 SPINAL OSTEOARTHRITIS 278 0.0316
194 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 302 0.0316
195 PSYCHOLOGICAL TRAUMA 273 0.0316
196 BLOOD IRON DECREASED 375 0.0316
197 TRANSFUSION 331 0.0316
198 PRODUCTIVE COUGH 1504 0.0315
199 ARTERIOSCLEROSIS 296 0.0314
200 WHEEZING 1864 0.0314
201 LIP SWELLING 1046 0.0314
202 FAECES SOFT 228 0.0313
203 ARTERIOSCLEROSIS CORONARY ARTERY 207 0.0312
204 SKIN ULCER 801 0.0310
205 COORDINATION ABNORMAL 432 0.0309
206 HAEMODIALYSIS 260 0.0309
207 GENERALISED OEDEMA 383 0.0309
208 LOWER GASTROINTESTINAL HAEMORRHAGE 228 0.0308
209 GROIN PAIN 270 0.0307
210 DIABETES MELLITUS INADEQUATE CONTROL 544 0.0307
211 MYASTHENIA GRAVIS 248 0.0307
212 ACUTE PULMONARY OEDEMA 172 0.0306
213 DEPRESSED LEVEL OF CONSCIOUSNESS 1206 0.0305
214 PAROSMIA 230 0.0305
215 CLOSTRIDIUM DIFFICILE COLITIS 323 0.0304
216 GLUCOSE TOLERANCE IMPAIRED 180 0.0304
217 BOWEL MOVEMENT IRREGULARITY 233 0.0304
218 RENAL FAILURE ACUTE 1289 0.0303
219 SUBARACHNOID HAEMORRHAGE 309 0.0303
220 CORONARY ARTERY OCCLUSION 416 0.0303
221 TRANSIENT ISCHAEMIC ATTACK 1023 0.0303
222 PLEURAL EFFUSION 1845 0.0303
223 HYDRONEPHROSIS 226 0.0302
224 ELECTROCARDIOGRAM QT PROLONGED 1084 0.0301
225 ANAL INCONTINENCE 271 0.0301
226 LEFT VENTRICULAR DYSFUNCTION 201 0.0300
227 FLANK PAIN 281 0.0299
228 DIVERTICULUM 212 0.0298
229 RED BLOOD CELL SEDIMENTATION RATE INCREASED 330 0.0298
230 HIATUS HERNIA 386 0.0298
231 ANGIOPATHY 166 0.0296
232 MULTIPLE ORGAN DYSFUNCTION SYNDROME 838 0.0296
233 PROSTATIC SPECIFIC ANTIGEN INCREASED 407 0.0295
234 MENTAL STATUS CHANGES 820 0.0295
235 SYNCOPE 2946 0.0294
236 NEPHROPATHY TOXIC 330 0.0294
237 FAECES DISCOLOURED 636 0.0293
238 BLOOD PRESSURE DECREASED 1947 0.0293
239 VENTRICULAR EXTRASYSTOLES 304 0.0292
240 BODY HEIGHT DECREASED 313 0.0292
241 TRICUSPID VALVE INCOMPETENCE 232 0.0292
242 DUODENAL ULCER 206 0.0292
243 ATELECTASIS 282 0.0292
244 DYSARTHRIA 1098 0.0291
245 AORTIC ANEURYSM 221 0.0290
246 IMPAIRED QUALITY OF LIFE 415 0.0288
247 TACHYPNOEA 392 0.0288
248 HEART RATE IRREGULAR 651 0.0288
249 IMPAIRED GASTRIC EMPTYING 392 0.0287
250 URINE ODOUR ABNORMAL 168 0.0285
251 HEPATIC STEATOSIS 532 0.0285
252 BLOOD URINE PRESENT 542 0.0285
253 POLLAKIURIA 1189 0.0285
254 EXTRASYSTOLES 199 0.0285
255 OESOPHAGITIS 311 0.0284
256 HAEMORRHAGIC STROKE 222 0.0284
257 BLOOD ALBUMIN DECREASED 225 0.0283
258 HAIR TEXTURE ABNORMAL 378 0.0282
259 ISCHAEMIC STROKE 503 0.0282
260 ANGINA UNSTABLE 183 0.0281
261 PNEUMONIA ASPIRATION 702 0.0281
262 ERECTILE DYSFUNCTION 721 0.0281
263 PANCREATITIS ACUTE 631 0.0280
264 MOTOR DYSFUNCTION 286 0.0280
265 CEREBRAL INFARCTION 685 0.0280
266 PULMONARY HYPERTENSION 583 0.0280
267 PETECHIAE 292 0.0280
268 HAEMATOCRIT DECREASED 553 0.0279
269 ALTERED STATE OF CONSCIOUSNESS 604 0.0279
270 BALANCE DISORDER 2407 0.0278
271 UPPER-AIRWAY COUGH SYNDROME 229 0.0278
272 ORAL PAIN 622 0.0278
273 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1445 0.0277
274 MUSCULOSKELETAL CHEST PAIN 428 0.0276
275 RESPIRATORY FAILURE 2016 0.0276
276 HAEMOGLOBIN DECREASED 2837 0.0276
277 SLEEP APNOEA SYNDROME 527 0.0276
278 PERIPHERAL COLDNESS 379 0.0276
279 BLOOD COUNT ABNORMAL 418 0.0275
280 TOXIC EPIDERMAL NECROLYSIS 418 0.0275
281 PERICARDIAL EFFUSION 635 0.0274
282 EMPHYSEMA 277 0.0274
283 DELIRIUM 951 0.0274
284 THROMBOTIC MICROANGIOPATHY 267 0.0274
285 DRUG ERUPTION 485 0.0273
286 MUSCLE SPASTICITY 336 0.0273
287 HAEMATEMESIS 693 0.0273
288 PULMONARY CONGESTION 360 0.0273
289 ADRENAL INSUFFICIENCY 330 0.0272
290 SHOCK HAEMORRHAGIC 221 0.0271
291 EOSINOPHILIA 475 0.0271
292 DEHYDRATION 3610 0.0270
293 LETHARGY 1557 0.0270
294 OSTEOARTHRITIS 1145 0.0270
295 CHOLESTASIS 518 0.0269
296 MADAROSIS 313 0.0269
297 C-REACTIVE PROTEIN INCREASED 980 0.0269
298 PULMONARY MASS 401 0.0269
299 FALL 8925 0.0268
300 URINARY RETENTION 894 0.0268
301 RED BLOOD CELL COUNT DECREASED 762 0.0266
302 HYPOPHAGIA 680 0.0266
303 ECCHYMOSIS 182 0.0265
304 HAEMOGLOBIN ABNORMAL 170 0.0264
305 HAEMORRHOIDS 511 0.0262
306 RECTAL HAEMORRHAGE 1125 0.0262
307 LYMPHOEDEMA 181 0.0261
308 EATING DISORDER 557 0.0261
309 CONFUSIONAL STATE 4219 0.0261
310 MYOCARDIAL ISCHAEMIA 297 0.0261
311 DECREASED APPETITE 6058 0.0261
312 DYSURIA 960 0.0261
313 URINARY INCONTINENCE 772 0.0260
314 INTERNATIONAL NORMALISED RATIO INCREASED 740 0.0259
315 FLUID RETENTION 1320 0.0259
316 HALLUCINATION, VISUAL 547 0.0259
317 ASCITES 761 0.0259
318 HOSPICE CARE 255 0.0258
319 ANAEMIA 4923 0.0258
320 RENAL DISORDER 1199 0.0257
321 PRESYNCOPE 625 0.0257
322 PULMONARY ARTERIAL HYPERTENSION 372 0.0256
323 PURPURA 227 0.0256
324 HAEMATURIA 878 0.0256
325 MYOSITIS 230 0.0256
326 CONSTIPATION 5590 0.0256
327 CYSTITIS 813 0.0255
328 COVID-19 PNEUMONIA 301 0.0255
329 GASTROINTESTINAL HAEMORRHAGE 2129 0.0254
330 HAEMOPTYSIS 710 0.0254
331 PARKINSONISM 248 0.0254
332 CORONARY ARTERY DISEASE 769 0.0254
333 HAEMATOMA 657 0.0253
334 SINUS TACHYCARDIA 360 0.0253
335 VITAMIN D DECREASED 216 0.0252
336 UNRESPONSIVE TO STIMULI 651 0.0252
337 HYPERTHYROIDISM 365 0.0252
338 CELLULITIS 1269 0.0252
339 VENTRICULAR FIBRILLATION 279 0.0251
340 MOUTH HAEMORRHAGE 184 0.0251
341 SUPRAVENTRICULAR TACHYCARDIA 240 0.0250
342 ARTHRITIS 1971 0.0250
343 SEASONAL ALLERGY 354 0.0250
344 GAMMA-GLUTAMYLTRANSFERASE INCREASED 554 0.0250
345 INCREASED TENDENCY TO BRUISE 230 0.0250
346 PAPULE 176 0.0250
347 ENCEPHALOPATHY 613 0.0249
348 INTERSTITIAL LUNG DISEASE 1205 0.0249
349 GASTROENTERITIS 363 0.0248
350 MUSCULAR WEAKNESS 2818 0.0248
351 CARDIAC ARREST 2047 0.0248
352 MOUTH ULCERATION 521 0.0247
353 PYELONEPHRITIS 214 0.0247
354 HYPOALBUMINAEMIA 192 0.0247
355 PALPITATIONS 2883 0.0246
356 GASTROOESOPHAGEAL REFLUX DISEASE 1981 0.0246
357 INTERNAL HAEMORRHAGE 281 0.0246
358 CATARACT 1462 0.0245
359 SQUAMOUS CELL CARCINOMA 231 0.0245
360 GASTRIC ULCER 466 0.0245
361 SECRETION DISCHARGE 307 0.0245
362 APHTHOUS ULCER 190 0.0245
363 PNEUMONIA 7921 0.0244
364 HYPOKINESIA 355 0.0244
365 CARDIOTOXICITY 218 0.0244
366 PNEUMONIA BACTERIAL 224 0.0244
367 EPISTAXIS 1823 0.0243
368 DRY MOUTH 1977 0.0243
369 DYSPNOEA 13790 0.0243
370 RESPIRATORY TRACT CONGESTION 387 0.0243
371 BACTERAEMIA 289 0.0243
372 SMALL INTESTINAL OBSTRUCTION 299 0.0243
373 APHASIA 733 0.0242
374 CARDIAC FAILURE 1948 0.0242
375 NEURALGIA 590 0.0242
376 CHEST PAIN 4481 0.0242
377 BLOOD CALCIUM INCREASED 212 0.0241
378 GASTRITIS 636 0.0241
379 DIVERTICULITIS 669 0.0241
380 AGEUSIA 602 0.0241
381 ULCER 383 0.0241
382 EJECTION FRACTION DECREASED 374 0.0240
383 URINARY TRACT INFECTION 4100 0.0240
384 COUGH 6738 0.0240
385 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 560 0.0240
386 HYPOTHYROIDISM 767 0.0240
387 PELVIC FRACTURE 187 0.0240
388 BLOOD CREATINE PHOSPHOKINASE INCREASED 689 0.0239
389 ORAL DISORDER 175 0.0238
390 MUSCULOSKELETAL DISCOMFORT 409 0.0237
391 POOR QUALITY SLEEP 510 0.0237
392 RIGHT VENTRICULAR FAILURE 166 0.0237
393 SINUS DISORDER 469 0.0237
394 HAEMATOCHEZIA 1305 0.0236
395 SWELLING FACE 1537 0.0236
396 AFFECT LABILITY 227 0.0236
397 VITAMIN D DEFICIENCY 230 0.0236
398 GLAUCOMA 454 0.0236
399 THIRST 421 0.0235
400 ASTHENIA 8849 0.0235
401 FEELING COLD 655 0.0235
402 MUSCLE ATROPHY 298 0.0235
403 SPINAL PAIN 275 0.0234
404 LOWER RESPIRATORY TRACT INFECTION 1065 0.0234
405 RENAL PAIN 248 0.0234
406 PLATELET COUNT INCREASED 305 0.0234
407 CHROMATURIA 528 0.0234
408 CONTUSION 2251 0.0234
409 PULMONARY FIBROSIS 448 0.0233
410 ABNORMAL FAECES 191 0.0233
411 AGRANULOCYTOSIS 433 0.0233
412 MYALGIA 3959 0.0233
413 BLOOD THYROID STIMULATING HORMONE INCREASED 214 0.0232
414 HEAD INJURY 734 0.0232
415 RESPIRATORY DISTRESS 640 0.0232
416 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1111 0.0231
417 FLATULENCE 1311 0.0231
418 SPINAL COMPRESSION FRACTURE 191 0.0231
419 LUNG INFILTRATION 204 0.0231
420 FEBRILE NEUTROPENIA 1530 0.0230
421 DIARRHOEA 14881 0.0230
422 WHITE BLOOD CELL COUNT INCREASED 883 0.0230
423 PHARYNGEAL SWELLING 225 0.0230
424 PAIN IN JAW 651 0.0230
425 CHEST DISCOMFORT 2352 0.0229
426 TINNITUS 1055 0.0229
427 MUSCULOSKELETAL PAIN 1203 0.0229
428 LIMB DISCOMFORT 710 0.0229
429 MYOCLONUS 273 0.0229
430 DISORIENTATION 907 0.0229
431 FACIAL PAIN 204 0.0228
432 DIALYSIS 324 0.0228
433 RESPIRATORY TRACT INFECTION 594 0.0228
434 SEPSIS 2541 0.0228
435 HEAD DISCOMFORT 402 0.0227
436 COGNITIVE DISORDER 1057 0.0226
437 BLOOD TEST ABNORMAL 318 0.0226
438 DIZZINESS 11278 0.0226
439 HEPATOMEGALY 222 0.0226
440 CHOLECYSTITIS 269 0.0226
441 DECREASED ACTIVITY 243 0.0225
442 ARRHYTHMIA 1066 0.0225
443 HAEMORRHAGE INTRACRANIAL 336 0.0224
444 BLISTER 1259 0.0224
445 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 174 0.0224
446 RASH MACULO-PAPULAR 498 0.0224
447 NEUTROPHIL COUNT INCREASED 229 0.0223
448 CEREBRAL HAEMORRHAGE 798 0.0223
449 ILEUS 277 0.0223
450 WEIGHT DECREASED 6221 0.0223
451 INTERVERTEBRAL DISC DEGENERATION 206 0.0222
452 SNEEZING 499 0.0222
453 DRY THROAT 226 0.0222
454 MEDICATION ERROR 1235 0.0222
455 CARDIO-RESPIRATORY ARREST 928 0.0222
456 ASPIRATION 243 0.0222
457 FULL BLOOD COUNT DECREASED 447 0.0222
458 MOBILITY DECREASED 1593 0.0221
459 DYSSTASIA 647 0.0221
460 HOT FLUSH 1670 0.0221
461 LOCAL SWELLING 386 0.0221
462 RIB FRACTURE 454 0.0220
463 VERTIGO 1345 0.0220
464 VENTRICULAR TACHYCARDIA 364 0.0220
465 CHOKING 430 0.0220
466 SKIN LESION 604 0.0220
467 SCIATICA 350 0.0219
468 ABDOMINAL PAIN 5103 0.0219
469 PAIN IN EXTREMITY 6462 0.0219
470 SKIN HAEMORRHAGE 324 0.0218
471 SKIN LACERATION 237 0.0218
472 DYSPEPSIA 2139 0.0217
473 MUCOSAL INFLAMMATION 569 0.0217
474 ORAL CANDIDIASIS 286 0.0217
475 CLOSTRIDIUM DIFFICILE INFECTION 474 0.0217
476 DYSPHAGIA 2057 0.0216
477 PNEUMONITIS 590 0.0216
478 GENERAL PHYSICAL HEALTH DETERIORATION 2502 0.0216
479 GAIT DISTURBANCE 4134 0.0216
480 BLOOD ALKALINE PHOSPHATASE INCREASED 536 0.0216
481 ROTATOR CUFF SYNDROME 277 0.0215
482 FREQUENT BOWEL MOVEMENTS 582 0.0215
483 CHOLELITHIASIS 706 0.0215
484 HEART RATE INCREASED 2132 0.0215
485 MUSCLE SPASMS 3946 0.0215
486 DYSPHONIA 1254 0.0214
487 GLYCOSYLATED HAEMOGLOBIN INCREASED 541 0.0214
488 DECUBITUS ULCER 174 0.0213
489 PRODUCT PRESCRIBING ERROR 508 0.0213
490 PNEUMOCYSTIS JIROVECII PNEUMONIA 214 0.0213
491 NECK PAIN 1191 0.0213
492 FATIGUE 16575 0.0213
493 ESCHERICHIA INFECTION 175 0.0213
494 LOSS OF CONSCIOUSNESS 2725 0.0212
495 ASTHMA 2397 0.0212
496 RHINORRHOEA 1368 0.0211
497 ANHEDONIA 555 0.0211
498 MALNUTRITION 236 0.0211
499 DYSGEUSIA 1563 0.0210
500 PLATELET COUNT DECREASED 2242 0.0210
501 METASTASES TO LUNG 243 0.0210
502 LOCALISED INFECTION 508 0.0210
503 RASH PRURITIC 1138 0.0210
504 VITREOUS FLOATERS 206 0.0209
505 POISONING DELIBERATE 198 0.0209
506 TOXIC SKIN ERUPTION 210 0.0208
507 STENT PLACEMENT 168 0.0208
508 COAGULOPATHY 346 0.0207
509 ABDOMINAL DISTENSION 2167 0.0207
510 ASPARTATE AMINOTRANSFERASE INCREASED 1102 0.0207
511 WEIGHT FLUCTUATION 217 0.0207
512 ALANINE AMINOTRANSFERASE INCREASED 1271 0.0207
513 NERVE COMPRESSION 191 0.0207
514 TOOTH INFECTION 272 0.0206
515 PRURITUS GENERALISED 446 0.0206
516 PARAESTHESIA ORAL 297 0.0206
517 THYROID DISORDER 317 0.0205
518 PANCYTOPENIA 1149 0.0205
519 BACK PAIN 4766 0.0205
520 OROPHARYNGEAL PAIN 1896 0.0205
521 LIVER FUNCTION TEST ABNORMAL 595 0.0204
522 FACIAL PARALYSIS 174 0.0204
523 TACHYCARDIA 1813 0.0204
524 SPLENOMEGALY 239 0.0204
525 PALLOR 555 0.0204
526 SLEEP DISORDER 1438 0.0204
527 DRUG-INDUCED LIVER INJURY 639 0.0203
528 BLOOD LACTATE DEHYDROGENASE INCREASED 322 0.0203
529 CARDIAC FAILURE CONGESTIVE 1632 0.0203
530 EAR DISCOMFORT 208 0.0202
531 INTERVERTEBRAL DISC PROTRUSION 443 0.0202
532 NASAL CONGESTION 1190 0.0202
533 HEPATOCELLULAR INJURY 287 0.0202
534 HALLUCINATION 1525 0.0202
535 JAUNDICE 543 0.0202
536 INCONTINENCE 212 0.0200
537 HEPATIC FUNCTION ABNORMAL 748 0.0200
538 EOSINOPHIL COUNT INCREASED 167 0.0200
539 JOINT INJURY 427 0.0200
540 SKIN DISCOLOURATION 918 0.0200
541 BLINDNESS UNILATERAL 281 0.0199
542 DIPLOPIA 517 0.0199
543 DIABETES MELLITUS 1516 0.0199
544 KIDNEY INFECTION 390 0.0199
545 MIDDLE INSOMNIA 371 0.0198
546 ABDOMINAL DISCOMFORT 3318 0.0198
547 FEEDING DISORDER 401 0.0198
548 VOMITING 9272 0.0197
549 BRAIN FOG 309 0.0197
550 POOR VENOUS ACCESS 204 0.0197
551 MALIGNANT MELANOMA 264 0.0197
552 INFUSION SITE ERYTHEMA 166 0.0197
553 SKIN PLAQUE 166 0.0197
554 SEDATION 515 0.0196
555 TUMOUR LYSIS SYNDROME 173 0.0196
556 COLITIS 744 0.0196
557 STEVENS-JOHNSON SYNDROME 436 0.0196
558 EXOSTOSIS 179 0.0196
559 TOOTH FRACTURE 216 0.0196
560 HIP FRACTURE 627 0.0195
561 THROAT IRRITATION 874 0.0195
562 NIGHT SWEATS 627 0.0194
563 ARTHRALGIA 8069 0.0194
564 INTENTIONAL PRODUCT USE ISSUE 1690 0.0193
565 DIABETIC KETOACIDOSIS 463 0.0193
566 APPENDICITIS 180 0.0193
567 PULMONARY THROMBOSIS 210 0.0192
568 TOOTH ABSCESS 196 0.0192
569 BRONCHITIS 1423 0.0192
570 BACTERIAL INFECTION 358 0.0192
571 MUSCLE STRAIN 166 0.0192
572 HEPATIC ENCEPHALOPATHY 179 0.0192
573 LIMB INJURY 521 0.0192
574 MUSCULOSKELETAL STIFFNESS 1679 0.0191
575 DIARRHOEA HAEMORRHAGIC 179 0.0191
576 ATAXIA 227 0.0191
577 OSTEOPENIA 290 0.0191
578 STOMATITIS 1157 0.0191
579 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 323 0.0190
580 JOINT DISLOCATION 201 0.0190
581 MALAISE 8330 0.0190
582 PHARYNGEAL OEDEMA 292 0.0190
583 BLOOD GLUCOSE FLUCTUATION 208 0.0190
584 COLD SWEAT 334 0.0189
585 PHOTOSENSITIVITY REACTION 312 0.0189
586 OSTEOPOROSIS 777 0.0189
587 ECONOMIC PROBLEM 286 0.0189
588 FEELING HOT 1156 0.0188
589 SWELLING 1763 0.0188
590 CEREBROVASCULAR ACCIDENT 3183 0.0188
591 APATHY 274 0.0188
592 ABDOMINAL PAIN UPPER 3865 0.0188
593 LIVER FUNCTION TEST INCREASED 403 0.0188
594 HYPERSOMNIA 538 0.0187
595 CONTRAINDICATED PRODUCT ADMINISTERED 566 0.0187
596 LUNG DISORDER 915 0.0187
597 COLON CANCER 278 0.0186
598 NEUROPATHY PERIPHERAL 1774 0.0186
599 BLADDER DISORDER 185 0.0186
600 BLOOD BILIRUBIN INCREASED 503 0.0186
601 SOMNOLENCE 3744 0.0186
602 CANDIDA INFECTION 314 0.0186
603 RETCHING 396 0.0186
604 METASTASES TO LIVER 326 0.0185
605 INFLUENZA 2067 0.0185
606 NEPHROLITHIASIS 850 0.0185
607 MUSCLE TIGHTNESS 300 0.0185
608 OBESITY 295 0.0185
609 BLOOD CHOLESTEROL INCREASED 863 0.0185
610 INFLAMMATION 955 0.0185
611 GAIT INABILITY 618 0.0185
612 NIGHTMARE 638 0.0184
613 EYE HAEMORRHAGE 245 0.0183
614 DEMENTIA 513 0.0183
615 ANKLE FRACTURE 284 0.0183
616 MASS 256 0.0183
617 SEPTIC SHOCK 797 0.0183
618 DEPRESSED MOOD 966 0.0183
619 TENDERNESS 190 0.0182
620 CARPAL TUNNEL SYNDROME 255 0.0182
621 PARAESTHESIA 2859 0.0182
622 JOINT STIFFNESS 476 0.0181
623 MOVEMENT DISORDER 582 0.0181
624 PNEUMOTHORAX 286 0.0180
625 GENERALISED TONIC-CLONIC SEIZURE 298 0.0180
626 MYOCARDITIS 206 0.0180
627 ERUCTATION 347 0.0179
628 THROMBOCYTOPENIA 2002 0.0179
629 APHONIA 249 0.0178
630 TENDONITIS 276 0.0178
631 NAUSEA 14108 0.0178
632 EYELID OEDEMA 207 0.0178
633 LIGAMENT SPRAIN 176 0.0178
634 HERNIA 342 0.0177
635 VISION BLURRED 2423 0.0176
636 BURSITIS 214 0.0176
637 TREMOR 2913 0.0175
638 DISSEMINATED INTRAVASCULAR COAGULATION 247 0.0175
639 BLOOD GLUCOSE ABNORMAL 324 0.0175
640 RESTLESSNESS 641 0.0175
641 DRUG LEVEL DECREASED 178 0.0175
642 COMA 832 0.0175
643 GASTROINTESTINAL PAIN 192 0.0174
644 INTESTINAL OBSTRUCTION 657 0.0174
645 SARS-COV-2 TEST POSITIVE 230 0.0174
646 BLOOD TRIGLYCERIDES INCREASED 307 0.0174
647 CYTOPENIA 212 0.0173
648 BURNING SENSATION 1214 0.0173
649 INFUSION SITE PAIN 223 0.0173
650 HYPOAESTHESIA 2585 0.0173
651 NERVE INJURY 192 0.0173
652 BRAIN OEDEMA 218 0.0172
653 TYPE 2 DIABETES MELLITUS 580 0.0172
654 PULMONARY EMBOLISM 1637 0.0172
655 TREATMENT NONCOMPLIANCE 942 0.0172
656 RESTLESS LEGS SYNDROME 313 0.0172
657 PYREXIA 5943 0.0172
658 TENDON RUPTURE 212 0.0172
659 PRESCRIBED UNDERDOSE 342 0.0171
660 TOOTH DISORDER 380 0.0171
661 LYMPHOCYTE COUNT DECREASED 302 0.0171
662 HERPES ZOSTER 981 0.0171
663 INSOMNIA 4543 0.0170
664 DEVICE RELATED INFECTION 262 0.0170
665 PHARYNGITIS 211 0.0170
666 WOUND 475 0.0170
667 ORAL DISCOMFORT 236 0.0170
668 EAR PAIN 330 0.0170
669 LACRIMATION INCREASED 512 0.0169
670 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 435 0.0169
671 NASOPHARYNGITIS 3116 0.0169
672 EYE INFECTION 190 0.0168
673 CHILLS 1971 0.0168
674 PRODUCT ADMINISTRATION ERROR 339 0.0168
675 IMMUNODEFICIENCY 250 0.0168
676 QUALITY OF LIFE DECREASED 225 0.0168
677 HEPATITIS 429 0.0167
678 UPPER LIMB FRACTURE 334 0.0167
679 LYMPHOPENIA 237 0.0167
680 MACULAR DEGENERATION 200 0.0167
681 OSTEOMYELITIS 303 0.0167
682 SENSORY DISTURBANCE 268 0.0167
683 RASH MACULAR 583 0.0167
684 DISTURBANCE IN ATTENTION 899 0.0167
685 HEADACHE 10422 0.0166
686 COVID-19 2915 0.0166
687 TRANSAMINASES INCREASED 369 0.0166
688 PANCREATITIS 876 0.0166
689 ARTHROPATHY 921 0.0166
690 SPEECH DISORDER 864 0.0165
691 INCREASED APPETITE 315 0.0165
692 BACK DISORDER 268 0.0165
693 WHITE BLOOD CELL COUNT DECREASED 1784 0.0164
694 EYE SWELLING 612 0.0164
695 BONE PAIN 961 0.0164
696 AMNESIA 1063 0.0163
697 FLUSHING 1660 0.0163
698 POISONING 205 0.0163
699 BREAST PAIN 174 0.0163
700 ABDOMINAL PAIN LOWER 412 0.0163
701 SLUGGISHNESS 166 0.0163
702 SKIN INFECTION 182 0.0162
703 PRURITUS 6226 0.0162
704 NEOPLASM 186 0.0162
705 POST PROCEDURAL HAEMORRHAGE 188 0.0161
706 MALIGNANT NEOPLASM PROGRESSION 1653 0.0161
707 RESPIRATORY ARREST 444 0.0161
708 MUSCLE TWITCHING 371 0.0161
709 LIVER DISORDER 713 0.0161
710 INTESTINAL PERFORATION 180 0.0160
711 SINUSITIS 1643 0.0160
712 DELUSION 249 0.0160
713 LUNG INFECTION 249 0.0160
714 SCRATCH 169 0.0160
715 WRIST FRACTURE 192 0.0160
716 HEPATIC CIRRHOSIS 300 0.0159
717 CYST 198 0.0159
718 NODULE 208 0.0159
719 NEUTROPHIL COUNT DECREASED 649 0.0159
720 MEMORY IMPAIRMENT 2185 0.0159
721 LYMPHADENOPATHY 562 0.0159
722 THERAPY CESSATION 815 0.0159
723 PLASMA CELL MYELOMA 619 0.0158
724 ANXIETY 4506 0.0158
725 BLOOD GLUCOSE DECREASED 760 0.0158
726 BEDRIDDEN 208 0.0158
727 DRUG INTOLERANCE 1526 0.0158
728 PHOTOPHOBIA 297 0.0158
729 GASTROENTERITIS VIRAL 285 0.0158
730 DEEP VEIN THROMBOSIS 1024 0.0157
731 DISCOMFORT 961 0.0157
732 CONDITION AGGRAVATED 4785 0.0157
733 LIVER INJURY 386 0.0157
734 INFUSION RELATED REACTION 1042 0.0157
735 DEAFNESS 411 0.0157
736 NERVOUSNESS 820 0.0157
737 WEIGHT INCREASED 3512 0.0157
738 PAIN 9610 0.0156
739 HYPERHIDROSIS 2015 0.0156
740 BONE DISORDER 285 0.0156
741 BODY TEMPERATURE INCREASED 319 0.0156
742 WOUND INFECTION 171 0.0156
743 FOOT FRACTURE 295 0.0155
744 THERAPY INTERRUPTED 1112 0.0155
745 TOOTHACHE 281 0.0155
746 SKIN CANCER 334 0.0155
747 THROMBOSIS 1244 0.0154
748 DERMATITIS 324 0.0154
749 SPINAL FRACTURE 309 0.0154
750 UPPER RESPIRATORY TRACT INFECTION 712 0.0154
751 DISEASE RECURRENCE 732 0.0154
752 EYE PAIN 867 0.0154
753 OVERDOSE 3312 0.0153
754 ALOPECIA 3014 0.0153
755 ORAL HERPES 299 0.0153
756 FACE OEDEMA 258 0.0153
757 VISUAL IMPAIRMENT 1894 0.0153
758 ACCIDENTAL OVERDOSE 559 0.0153
759 INTENTIONAL DOSE OMISSION 435 0.0152
760 HEPATIC ENZYME INCREASED 1040 0.0152
761 RESPIRATORY DISORDER 455 0.0152
762 KNEE ARTHROPLASTY 320 0.0152
763 RASH 6625 0.0152
764 SCAB 173 0.0152
765 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 260 0.0152
766 OCULAR DISCOMFORT 170 0.0151
767 FEELING ABNORMAL 3623 0.0151
768 POLYNEUROPATHY 181 0.0151
769 CARDIOMYOPATHY 223 0.0151
770 RASH ERYTHEMATOUS 720 0.0150
771 FOOT DEFORMITY 166 0.0150
772 DEPRESSION 3407 0.0150
773 MUSCLE RIGIDITY 179 0.0150
774 VIRAL INFECTION 498 0.0150
775 INTENTIONAL PRODUCT MISUSE 1310 0.0149
776 PRODUCT DOSE OMISSION 975 0.0149
777 HYPOAESTHESIA ORAL 225 0.0149
778 CYTOKINE RELEASE SYNDROME 299 0.0149
779 SCAR 255 0.0149
780 GLOSSODYNIA 333 0.0149
781 SPINAL OPERATION 183 0.0148
782 MUSCULOSKELETAL DISORDER 282 0.0148
783 PARALYSIS 212 0.0148
784 SKIN EXFOLIATION 1249 0.0148
785 BLINDNESS 603 0.0148
786 ABSCESS 236 0.0148
787 GASTROINTESTINAL DISORDER 1325 0.0148
788 GASTRIC HAEMORRHAGE 170 0.0148
789 POST PROCEDURAL COMPLICATION 283 0.0147
790 SKIN DISORDER 491 0.0147
791 JOINT RANGE OF MOTION DECREASED 196 0.0146
792 HEPATOTOXICITY 325 0.0146
793 BLOOD GLUCOSE INCREASED 2749 0.0146
794 ANOSMIA 211 0.0146
795 RASH GENERALISED 377 0.0145
796 SYNOVITIS 262 0.0145
797 PRODUCT SUBSTITUTION ISSUE 833 0.0145
798 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1026 0.0144
799 DERMATITIS ALLERGIC 181 0.0144
800 FEMUR FRACTURE 445 0.0144
801 CARDIAC DISORDER 1336 0.0143
802 NEUROTOXICITY 250 0.0143
803 ANAPHYLACTIC REACTION 786 0.0142
804 PSORIASIS 1854 0.0142
805 NEUROLEPTIC MALIGNANT SYNDROME 168 0.0142
806 INTRAOCULAR PRESSURE INCREASED 181 0.0141
807 STAPHYLOCOCCAL INFECTION 467 0.0141
808 EYE DISORDER 465 0.0141
809 HEPATIC CYTOLYSIS 180 0.0141
810 MULTI-ORGAN FAILURE 244 0.0141
811 EYE PRURITUS 473 0.0141
812 DYSKINESIA 572 0.0141
813 CONJUNCTIVITIS 261 0.0141
814 LABORATORY TEST ABNORMAL 415 0.0140
815 THERAPY NON-RESPONDER 631 0.0140
816 AGITATION 1029 0.0140
817 FUNGAL INFECTION 466 0.0140
818 RASH PAPULAR 313 0.0140
819 PRODUCT TASTE ABNORMAL 189 0.0139
820 FRACTURE 264 0.0139
821 BRONCHOSPASM 199 0.0139
822 IMPAIRED HEALING 456 0.0139
823 HIP ARTHROPLASTY 212 0.0138
824 INFECTION 2003 0.0138
825 DISEASE PROGRESSION 1637 0.0138
826 HEPATIC FAILURE 417 0.0138
827 EPILEPSY 422 0.0138
828 SEIZURE 1594 0.0138
829 OFF LABEL USE 12063 0.0138
830 MYOCARDIAL INFARCTION 2402 0.0138
831 FEELING JITTERY 261 0.0137
832 THROAT TIGHTNESS 370 0.0137
833 HYPOACUSIS 587 0.0136
834 ERYTHEMA 2796 0.0136
835 RHEUMATOID ARTHRITIS 1543 0.0136
836 TOOTH EXTRACTION 169 0.0136
837 NEOPLASM PROGRESSION 472 0.0136
838 VISUAL ACUITY REDUCED 450 0.0135
839 ECZEMA 705 0.0135
840 PERITONITIS 279 0.0135
841 ANAPHYLACTIC SHOCK 346 0.0134
842 NEUTROPENIA 1815 0.0133
843 LEUKOPENIA 667 0.0133
844 PRODUCT DISPENSING ERROR 290 0.0133
845 HAEMORRHAGE 1391 0.0133
846 EYE IRRITATION 760 0.0132
847 CYANOSIS 207 0.0131
848 CYTOMEGALOVIRUS INFECTION 218 0.0131
849 ILLNESS 1347 0.0131
850 PRODUCT USE COMPLAINT 205 0.0130
851 GASTRIC DISORDER 446 0.0130
852 PRODUCT DOSE OMISSION IN ERROR 368 0.0130
853 IMPAIRED WORK ABILITY 277 0.0129
854 INFLUENZA LIKE ILLNESS 1064 0.0129
855 METASTASES TO BONE 212 0.0129
856 ABASIA 319 0.0129
857 HALLUCINATION, AUDITORY 204 0.0128
858 DRY EYE 637 0.0127
859 GALLBLADDER DISORDER 227 0.0127
860 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2276 0.0126
861 OCULAR HYPERAEMIA 595 0.0125
862 ABNORMAL DREAMS 344 0.0124
863 LOWER LIMB FRACTURE 238 0.0124
864 PROCEDURAL PAIN 342 0.0123
865 OSTEONECROSIS OF JAW 305 0.0123
866 MENTAL IMPAIRMENT 295 0.0122
867 COLITIS ULCERATIVE 542 0.0121
868 FIBROMYALGIA 293 0.0120
869 PRODUCT USE ISSUE 2256 0.0120
870 SKIN REACTION 169 0.0120
871 SYSTEMIC LUPUS ERYTHEMATOSUS 425 0.0120
872 PSORIATIC ARTHROPATHY 484 0.0119
873 DRUG PRESCRIBING ERROR 228 0.0119
874 ROAD TRAFFIC ACCIDENT 496 0.0118
875 EAR INFECTION 315 0.0118
876 PRESCRIBED OVERDOSE 228 0.0118
877 MYELODYSPLASTIC SYNDROME 170 0.0117
878 URTICARIA 1967 0.0117
879 HYPERSENSITIVITY 2172 0.0117
880 ACTIVITIES OF DAILY LIVING IMPAIRED 230 0.0116
881 PERICARDITIS 195 0.0116
882 SKIN FISSURES 226 0.0116
883 PRODUCT PHYSICAL ISSUE 233 0.0115
884 THINKING ABNORMAL 214 0.0115
885 IRRITABLE BOWEL SYNDROME 246 0.0115
886 PANIC ATTACK 416 0.0114
887 MOOD ALTERED 311 0.0114
888 UNEVALUABLE EVENT 862 0.0114
889 MENTAL DISORDER 494 0.0113
890 CARDIOVASCULAR DISORDER 288 0.0113
891 HOSPITALISATION 1738 0.0113
892 BONE MARROW FAILURE 229 0.0113
893 MANIA 184 0.0112
894 PRODUCT USE IN UNAPPROVED INDICATION 2737 0.0110
895 THERAPEUTIC PRODUCT EFFECT DECREASED 493 0.0110
896 MIGRAINE 1036 0.0108
897 ADVERSE DRUG REACTION 974 0.0108
898 MULTIPLE FRACTURES 178 0.0108
899 DRY SKIN 1446 0.0108
900 FEAR 291 0.0108
901 PRODUCT DOSE OMISSION ISSUE 3130 0.0106
902 PRODUCT AVAILABILITY ISSUE 240 0.0105
903 INCORRECT PRODUCT ADMINISTRATION DURATION 227 0.0105
904 PAIN OF SKIN 282 0.0105
905 DRUG DOSE OMISSION 1729 0.0104
906 THERAPEUTIC RESPONSE UNEXPECTED 464 0.0103
907 PARANOIA 178 0.0103
908 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 721 0.0101
909 SURGERY 591 0.0101
910 DRUG EFFECT INCOMPLETE 366 0.0101
911 PSYCHOMOTOR HYPERACTIVITY 167 0.0101
912 LUNG NEOPLASM MALIGNANT 409 0.0099
913 NERVOUS SYSTEM DISORDER 310 0.0099
914 ILL-DEFINED DISORDER 603 0.0099
915 SUICIDAL IDEATION 908 0.0099
916 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 543 0.0099
917 NEEDLE ISSUE 286 0.0098
918 TOOTH LOSS 203 0.0098
919 PSYCHOTIC DISORDER 289 0.0098
920 DRUG INEFFECTIVE 12842 0.0097
921 INJECTION SITE MASS 360 0.0097
922 DEATH 8171 0.0095
923 EXTRAPYRAMIDAL DISORDER 235 0.0095
924 PRODUCT PRESCRIBING ISSUE 206 0.0094
925 ANGER 314 0.0093
926 EXPIRED PRODUCT ADMINISTERED 308 0.0093
927 UNDERDOSE 666 0.0091
928 ABNORMAL BEHAVIOUR 360 0.0091
929 THERAPEUTIC RESPONSE SHORTENED 299 0.0090
930 PRODUCT QUALITY ISSUE 1224 0.0090
931 THERAPEUTIC RESPONSE DECREASED 542 0.0089
932 EMOTIONAL DISORDER 274 0.0089
933 EMOTIONAL DISTRESS 1065 0.0088
934 APPLICATION SITE PRURITUS 195 0.0086
935 BONE DENSITY DECREASED 268 0.0085
936 INCORRECT DOSE ADMINISTERED 1950 0.0085
937 AGGRESSION 424 0.0085
938 INCORRECT DRUG ADMINISTRATION DURATION 234 0.0083
939 WITHDRAWAL SYNDROME 349 0.0083
940 CRYING 300 0.0082
941 IRRITABILITY 493 0.0082
942 INTENTIONAL DRUG MISUSE 171 0.0082
943 DRUG ADMINISTRATION ERROR 251 0.0082
944 ADVERSE EVENT 745 0.0081
945 NEOPLASM MALIGNANT 533 0.0080
946 MOOD SWINGS 251 0.0079
947 PREMATURE BABY 236 0.0078
948 DRUG EFFECT DECREASED 404 0.0075
949 EXTRA DOSE ADMINISTERED 297 0.0073
950 PANCREATIC CARCINOMA 210 0.0073
951 INJECTION SITE BRUISING 576 0.0072
952 WRONG TECHNIQUE IN DRUG USAGE PROCESS 262 0.0072
953 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1461 0.0072
954 DEVICE DELIVERY SYSTEM ISSUE 192 0.0070
955 INJECTION SITE HAEMORRHAGE 560 0.0070
956 CONVULSION 399 0.0070
957 DERMATITIS ATOPIC 362 0.0069
958 DRUG RESISTANCE 176 0.0068
959 DEVICE ISSUE 612 0.0068
960 DEVICE MALFUNCTION 479 0.0068
961 TREATMENT FAILURE 554 0.0067
962 ACNE 500 0.0066
963 INJURY 458 0.0065
964 APPLICATION SITE ERYTHEMA 170 0.0065
965 VAGINAL HAEMORRHAGE 275 0.0063
966 INJECTION SITE PRURITUS 418 0.0062
967 DRUG ABUSE 513 0.0062
968 MULTIPLE SCLEROSIS RELAPSE 413 0.0060
969 INJECTION SITE PAIN 1828 0.0060
970 TARDIVE DYSKINESIA 166 0.0059
971 INJECTION SITE SWELLING 445 0.0058
972 SKIN BURNING SENSATION 416 0.0058
973 SKIN IRRITATION 257 0.0056
974 MULTIPLE SCLEROSIS 267 0.0056
975 OSTEONECROSIS 183 0.0056
976 FOETAL EXPOSURE DURING PREGNANCY 432 0.0053
977 PROSTATE CANCER 419 0.0052
978 PRODUCT ADHESION ISSUE 185 0.0052
979 INJECTION SITE ERYTHEMA 637 0.0051
980 INJECTION SITE REACTION 335 0.0049
981 DEVICE DISLOCATION 210 0.0048
982 EXPOSURE DURING PREGNANCY 291 0.0047
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 216 0.0046
984 RENAL CANCER 215 0.0045
985 BREAST CANCER 406 0.0044
986 NO ADVERSE EVENT 787 0.0043
987 DEVICE LEAKAGE 180 0.0041
988 ACCIDENTAL EXPOSURE TO PRODUCT 409 0.0040
989 MATERNAL EXPOSURE DURING PREGNANCY 350 0.0039
990 DRUG DOSE OMISSION BY DEVICE 285 0.0036
991 PRODUCT STORAGE ERROR 294 0.0034
992 BLADDER CANCER 187 0.0032
993 DRUG WITHDRAWAL SYNDROME 266 0.0030
994 DRUG DEPENDENCE 225 0.0014